The National Institute for Communicable Diseases (NICD) has issued a statement assuring the public that there is no need to panic about the reported cases of human metapneumovirus (HMPV).

Most people who catch the flu have only the above mild symptoms and recover on their own without the use of antiviral ...

As of Dec. 28, Michigan’s flu shot uptake -- less than 2.5 million doses -- sat far below its goal of 4 million doses ...

Patients are piling up in Minnesota emergency rooms once again, but it’s not just from COVID-19. State health officials say ...

Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

Respiratory virus season is worsening. Nearly five years since the COVID-19 pandemic took hold, disease experts are urging ...

The best way to protect yourself from the flu and COVID is to get vaccinated. This can reduce your chances of getting sick ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

Even as the world fixates on hMPV, a genuine pandemic threat is emerging in the form of H5N1 bird flu. The virus has jumped ...

Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing.

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

As respiratory illness season peaks, another virus is making its rounds—Human Metapneumovirus (HMPV). Often overlooked, HMPV ...